(Q42277140)

19 October 2017

title

Etoposide-related myocardial infarction (English)

1 reference

19 October 2017

main subject

myocardial infarction

1 reference

Airey CL

1

1 reference

19 October 2017

Dodwell DJ

series ordinal

2

1 reference

19 October 2017

Joffe JK

series ordinal

3

1 reference

19 October 2017

Jones WG

series ordinal

4

1 reference

19 October 2017

publication date

1 January 1995

1 reference

19 October 2017

1 reference

19 October 2017

volume

7

1 reference

19 October 2017

issue

2

1 reference

19 October 2017

page(s)

135

1 reference

Electrocardiographic changes simulating acute myocardial infarction or ischemia associated with combination chemotherapy with etoposide, cisplatin, and 5-fluorouracil

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980819-2

7 January 2021

Myocardial ischemia after treatment with methotrexate, etoposide and cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980819-2

7 January 2021

Acute coronary thrombosis and myocardial ischemia following chemotherapy of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980819-2

7 January 2021

A phase I trial of continuous infusion VP16-213 (etoposide).

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980819-2

7 January 2021

Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980819-2

7 January 2021

Prinzmetal's angina during cyclophosphamide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980819-2

7 January 2021

Prinzmetal's angina during 5-fluorouracil chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980819-2

7 January 2021

10.1016/S0936-6555(05)80819-2

Identifiers

DOI

1 reference

19 October 2017

1 reference